Details for Patent: 7,229,982
✉ Email this page to a colleague
Summary for Patent: 7,229,982
Title: | Pharmaceutical formulation |
Abstract: | The instant invention provides a pharmaceutical composition comprised of a cholesterol absorption inhibitor and an HMG-CoA reductase inhibitor, one or more anti-oxidants, microcrystalline cellulose, hydroxypropyl methylcellulose, magnesium stearate and lactose. The composition need not contain ascorbic acid in order to obtain desirable stability. |
Inventor(s): | Moore; William D. (Hoddesdon, Hertfordshire, GB), Fitzpatrick; Shaun (Hoddesdon, Hertfordshire, GB), Seiler; Christian (Hertford, GB), Saklatvala; Robert (Hoddesdon, Hertfordshire, GB), Petts; Catherine R. (Hoddesdon, Hertfordshire, GB) |
Assignee: | |
Application Number: | 10/625,004 |
Patent Claim Types: see list of patent claims | Composition; Dosage form; Use; |
Drugs Protected by US Patent 7,229,982
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 7,229,982
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Argentina | 040588 | ⤷ Try a Trial | |||
Argentina | 067030 | ⤷ Try a Trial | |||
Austria | 393628 | ⤷ Try a Trial | |||
Australia | 2003261217 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |